SANAI HEALTH GP (01889) announced its interim results for the six months ended June 30, 2025. The group recorded revenue of HK$47.222 million, representing a year-over-year increase of 28.57%. The company reported a loss attributable to owners of HK$10.861 million, compared to a profit of HK$9.971 million in the same period last year. Loss per share was 7.1 cents. According to the announcement, the revenue increase was primarily attributed to higher revenue from pharmaceutical product sales by Beijing Hanyang during the period.